Clinical trial
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature…
NCT00143117 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143117 |
|---|---|
| Title | Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation |
| Official title | A Phase 2b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study to Assess the Efficacy and Safety of Oral UK-390,957 in Men With Premature Ejaculation |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Ejaculation |
| Intervention type | Drug |
| Interventions | UK-390, 957 |
| Enrollment | 460 |
| Start date | Aug 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Nov 7, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: